|
|
|
Volumn 282, Issue 5394, 1998, Pages 1626-1628
|
|
Cuba's billion-dollar biotech gamble
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CANCER VACCINE;
EPIDERMAL GROWTH FACTOR;
HEPATITIS B VACCINE;
HEPATITIS C VACCINE;
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
MENINGITIS VACCINE;
MONOCLONAL ANTIBODY;
STREPTOKINASE;
VIRUS VACCINE;
BIOMEDICINE;
BIOTECHNOLOGY;
CUBA;
GENETIC ENGINEERING;
GOVERNMENT;
MARKETING;
MEDICAL RESEARCH;
PRIORITY JOURNAL;
SHORT SURVEY;
ACADEMIES AND INSTITUTES;
BIOTECHNOLOGY;
CUBA;
POLITICS;
UNITED STATES;
HEPATITIS C VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS;
|
|
EID: 0032573482
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
|
Times cited : (8)
|
|
References (0)
|